Jan van de Winkel, President & Chief Executive Officer at Genmab, shared a post on LinkedIn:
“What becomes possible when you challenge the status quo and follow your curiosity to discover what science can truly make possible?
At Genmab, that question has guided us from the very beginning.
We set out with a bold ambition: to harness the power of antibodies to transform patients’ lives. That ambition has enabled us to reach patients around the world through our science.
But what inspires me most right now is not just what we’ve achieved. It’s how we are evolving with even greater intention.
We are taking greater ownership across the entire journey, from discovery through development, all the way to the patients we serve.
This is about expanding our impact.
For patients still waiting.
For the people behind every breakthrough innovation.
And for the future of medicine.
While we are transforming, our purpose remains unchanged.
At Genmab, science begins with people, and patients remain at the heart of everything we do.
And I’m energized by what we’re building next for patients.”
Proceed to the video attached to the post.
More posts about Genmab.